Sort
24,576 grants matching “microbiome”
DartCF: The Dartmouth Cystic Fibrosis Research Center
$1,208,158Dean R Madden · Dartmouth College · P30 · FY2023 · DK
DartCF: The Dartmouth Cystic Fibrosis Research Center
$1,208,158Dean R Madden · Dartmouth College · P30 · FY2024 · DK
Human Immune Monitoring Core
$1,207,964Holden T. Maecker · Stanford University · P01 · FY2025 · AI
Center for Molecular Studies in Digestive and Liver Diseases
$1,207,500Gary D. Wu · University Of Pennsylvania · P30 · FY2021 · DK
The Cleveland Digestive Diseases Research Core Center (DDRCC)
$1,207,500Fabio Cominelli · Case Western Reserve University · P30 · FY2025 · DK
Center for Molecular Studies in Digestive and Liver Diseases
$1,207,500Anil K Rustgi · University Of Pennsylvania · P30 · FY2017 · DK
TMAO and Initiation, Extent, and Clinical Onset of Atherosclerotic CVD
$1,207,201Dariush Mozaffarian · Tufts University Boston · R01 · FY2017 · HL
San Diego Digestive Diseases Research Center
$1,205,451Bernd G. Schnabl · University Of California, San Diego · P30 · FY2024 · DK
Encyclopedia of E. coli Genes and Metabolism (SRI Proposal ECU 09-676)
$1,205,333Peter D Karp · Sri International · U24 · FY2011 · GM
Molecular Subtypes for Targeted Therapies in Alcoholic Hepatitis
$1,205,194Ramon Bataller · Univ Of North Carolina Chapel Hill · U01 · FY2016 · AA
Pacific Northwest Center for Translational Environmental Health Research
$1,204,299Emily Ho · Oregon State University · P30 · FY2022 · ES
Pacific Northwest Center for Translational Environmental Health Research
$1,204,299Jamie Dewitt · Oregon State University · P30 · FY2023 · ES
Pacific Northwest Center for Translational Environmental Health Research
$1,204,299Jamie Dewitt · Oregon State University · P30 · FY2024 · ES
Pacific Northwest Center for Translational Environmental Health Research
$1,204,299Emily Ho · Oregon State University · P30 · FY2021 · ES
Translational Research Program in Colorectal Cancer Disparities
$1,203,951Ulrike Peters · Fred Hutchinson Cancer Research Center · P20 · FY2020 · CA
Pediatric Oncology Branch Behavioral Science Core
$1,203,016John Glod · Division Of Basic Sciences - Nci · ZID · FY2023 · CA
EF: Collaborative Research: MTM 2: Marine Invertebrate Microbiome Assembly, Diversification, and Coevolution
$1,202,860Kent A Hatch · Long Island University · · FY2021 · BIO
Engineered human intestinal organoids: a modular system to model enteric disease
$1,201,933Vincent B Young · University Of Michigan At Ann Arbor · U19 · FY2016 · AI
Multi-method investigation and characterization of the ocular microbiome
$1,200,972Cintia Sade De Paiva · Baylor College Of Medicine · U24 · FY2024 · EY
Dartmouth Lung Biology Center for Molecular, Cellular and Translational Research
$1,200,671Bruce A. Stanton · Dartmouth College · P30 · FY2014 · GM
California NeuroAIDS Tissue Network
$1,200,515David J Moore · University Of California, San Diego · U24 · FY2020 · MH
A Foundation for the Oral Microbiome and Metagenome
$1,200,286Jessica Leigh Mark Welch · Ada Forsyth Institute, Inc. · R01 · FY2025 · DE
SitS: Electrochemical signals to monitor soil microbiome structure and function
$1,200,000Haluk Beyenal · Washington State University · · FY2023 · ENG
TO EFFECTIVELY MITIGATE ANTIMICROBIAL RESISTANCE IN THE AGRICULTURAL ECOSYSTEM, THERE IS AN INCREASING PRESSURE TO REDUCE AND ELIMINATE THE USE OF IN-FEED ANTIBIOTICS FOR GROWTH PROMOTION AND DISEASE CONTROL IN FOOD ANIMALS. HOWEVER, LIMITING ANTIBIOTICS COULD COMPROMISE PRODUCTION EFFICIENCY AND ANIMAL HEALTH. THUS, DEVELOPING EFFECTIVE ALTERNATIVES TO ANTIBIOTICS IS URGENTLY NEEDED. BUILDING UPON OUR ACCUMULATIVE RESEARCH EFFORTS ON FUNCTIONAL MICROBIOME AS WELL AS MODULATION OF HOST INNATE IMMUNITY, WE HAVE DEVELOPED TWO TYPES OF INNOVATIVE SMALL MOLECULES, NAMELY BILE SALT HYDROLASE INHIBITORS AND HOST DEFENSE PEPTIDE-INDUCING COMPOUNDS, AS ALTERNATIVES TO ANTIBIOTICS FOR GROWTH PROMOTION AND DISEASE CONTROL IN POULTRY. IN THIS PROPOSAL, WE PROPOSE TO USE INNOVATIVE AND COST-EFFECTIVE ENCAPSULATION TECHNOLOGIES TO FURTHER IMPROVE THE EFFICACY OF THESE NATURAL COMPOUNDS FOR COMMERCIAL APPLICATIONS. WE ALSO WILL DEVELOP EFFECTIVE EXTENSION AND EDUCATION PROGRAMS WHICH ARE HIGHLY INTEGRATED WITH RESEARCH TO ENCOURAGE ADOPTION OF INNOVATIVE NON-ANTIBIOTIC STRATEGIES. THE PROPOSED WORK WAS DEVELOPED WITH SIGNIFICANT INPUTS FROM STAKEHOLDERS AND RECEIVED ENTHUSIASTIC SUPPORT FROM THE INDUSTRY. THIS MULTI-DISCIPLINARY PROJECT WILL BE CONDUCTED BY A HIGHLY QUALIFIED MULTI-INSTITUTIONAL TEAM WITH MAJOR PARTICIPANTS FROM TWO USDA EPSCOR INSTITUTIONS. THE OUTCOMES OF THE PROJECT WILL LEAD TO THE DEVELOPMENT OF TWO INNOVATIVE NON-ANTIBIOTIC FEEDING TECHNOLOGIES FOR IMMEDIATE ADOPTION AND COMMERCIALIZATION IN POULTRY AND POSSIBLY OTHER LIVESTOCK, THUS MITIGATING ANTIMICROBIAL RESISTANCE ACROSS THE FOOD CHAIN.
$1,200,000University Of Tennessee · · FY2018 · National Institute of Food and Agriculture
Investigating the Genetic, Cellular, and Metabolic Events Important for Urothelial Homeostasis and Response to Urinary Tract Infection
$1,200,000Cathy L Mendelsohn · Columbia University Health Sciences · U54 · FY2020 · DK